2021/01/25 | Press Release – ArchiMed’s BOMI Group enters new geographies and market segments through six Buy-and-Build acquisitions made over eight months

The aggressive, ongoing acquisition program is consolidating a fragmented industry and turning BOMI into a full-service, one-stop shop for international healthcare logistics. January 25, 2021 – Through six acquisitions carried out between May, 2020 and January, 2021, healthcare logistics specialist BOMI Group is adding some 20 percent to its annual revenues. Going forward, annual revenues are…

MORE

2021/01/25 | Press Release – ArchiMed’s Direct Healthcare Group sees annual revenue more than double through four Buy-and-Build purchases over nine months

The transactions – with more in the pipeline – put DHG on course to be the leading pan-European provider of products and solutions for the care of patients with limited mobility. January 25, 2021 – Direct Healthcare Group, a majority-owned portfolio company (and partner) of private equity healthcare specialist ArchiMed, increased its annual revenues in 2020…

MORE

2021/01/12 | Press Release – ArchiMed buys Germany’s Zyto Group of Cancer Diagnostics companies in partnership with owners and management

With ArchiMed’s backing, the group is expected to rapidly become a European leader in diagnostics for cutting-edge, precision medical treatments for cancer. January 12, 2021 – Private equity healthcare specialist, ArchiMed, announces its acquisition of the Zyto group of companies, a fully integrated developer, manufacturer and distributor of technologically advanced cancer diagnostics tests and equipment…

MORE

2021/01/05 | Press Release – ArchiMed’s NAMSA announces key acquisition of Syntactx

The purchase of Syntactx reinforces NAMSA’s position as the world’s leading one-stop shop for complex, outsourced medical device testing. January 5, 2021 – NAMSA, a portfolio company of global private equity healthcare specialist ArchiMed, announces the 100 percent purchase of Syntactx. NAMSA and Syntactx are contract research organizations, offering outsourced services for clinical trials and…

MORE